Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes — Stella

Recruiting

Back to Diabetes Mellitus, Type 1 trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Boston Medical Center, Boston, Massachusetts

Montefiore Einstein Medical Center, The Bronx, New York

Key details

Sponsor

Boston Medical Center

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~140 participants

Started

February 2025

Primary completion

September 2028

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov